TY - JOUR
T1 - Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe
T2 - A case-control study
AU - Alonso-Perez, Elisa
AU - Suarez-Gestal, Marian
AU - Calaza, Manuel
AU - Sebastiani, Gian D.
AU - Pullmann, Rudolf
AU - Papasteriades, Chryssa
AU - Kovacs, Attila
AU - Skopouli, Fotini N.
AU - Bijl, Marc
AU - Suarez, Ana
AU - Marchini, Maurizio
AU - Migliaresi, Sergio
AU - Carreira, Patricia
AU - Ordi-Ros, Josep
AU - Witte, Torsten
AU - Ruzickova, Sarka
AU - Santos, Maria J.
AU - Barizzone, Nadia
AU - Blanco, Francisco J.
AU - Lauwerys, Bernard R.
AU - Gomez-Reino, Juan J.
AU - Gonzalez, Antonio
N1 - Funding Information:
EA-P is the recipient of a predoctoral bursary from the Instituto de Salud Carlos III (Spain). This work was supported by Fondo de Investigacion Sanitaria of the Instituto de Salud Carlos III (Spain) grant 08/0744 and by RETICS Program RD08/0075 that are partially financed by the European Regional Development Fund of the European Union, and by grants from the Xunta de Galicia and BMBF KN Rheuma (C2.12 to TW). Other contributors to the European Consortium of SLE DNA Collections: Myriam Liz, Laboratorio de Investigacion 10 and Rheumatology Unit, Instituto de Investigacion Sanitaria - Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain; Reinhold E Schmidt, Division of Clinical Immunology, Department of Internal Medicine of the Hannover Medical School, Hannover, Germany; Iris Kappou-Rigatou, Department of Histocompatibility and Immunology, Evangelismos Hospital, Athens, Greece; Raffaella Scorza, Clinical Immunology, University of Milan and Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy; Emöke Endereffy, Department of Paediatrics, Albert Szent-Györgyi Clinical Centre, University of Szeged, Szeged, Hungary; Eva Balada, Internal Medicine, Research Laboratory in Autoimmune Diseases Hospital Vall d’Hebron, Barcelona, Spain; Cees G Kallenberg, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, the Netherlands; Filipe Vinagre, Rheumatology Department, Hospital Garcia de Orta, Almada (Portugal) and Rheumatology Research Unit, Instituto Medicina Molecular, Facultade de Medicina da Universidade de Lisboa, Portugal; Ctibor Dostal, Molecular Biology and Immunogenetics Department, Institute of Rheumatology. Prague, Czech Republic; Rudolf Pullmann Jr, Gerontology Research Center, National Institute on Aging, Nathan Shock Drive, Baltimore, Maryland, USA; Maria Mavromati, Pathophysiology Department, Athens University Medical School, Athens, Greece; Sandra D’Alfonso, Department of Medical Sciences and IRCAD, Eastern Piedmont University, Novara, Italy; Carmen Gutierrez, Department of Functional Biology, Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain; and Ignacio Rego, Laboratorio de Investigación Osteoarticular y del Envejecimiento, Servicio de Reumatología, CH Universitario A Coruña, A Coruña, Spain.
PY - 2012/4/27
Y1 - 2012/4/27
N2 - Introduction: We aimed to investigate whether the effect size of the systemic lupus erythematosus (SLE) risk alleles varies across European subpopulations.Methods: European SLE patients (n = 1,742) and ethnically matched healthy controls (n = 2,101) were recruited at 17 centres from 10 different countries. Only individuals with self-reported ancestry from the country of origin were included. In addition, participants were genotyped for top ancestry informative markers and for 25 SLE associated SNPs. The results were used to compare effect sizes between the Central Eureopan and Southern European subgroups.Results: Twenty of the 25 SNPs showed independent association with SLE, These SNPs showed a significant bias to larger effect sizes in the Southern subgroup, with 15/20 showing this trend (P = 0.019) and a larger mean odds ratio of the 20 SNPs (1.46 vs. 1.34, P = 0.02) as well as a larger difference in the number of risk alleles (2.06 vs. 1.63, P = 0.027) between SLE patients and controls than for Central Europeans. This bias was reflected in a very significant difference in the cumulative genetic risk score (4.31 vs. 3.48, P = 1.8 × 10 -32). Effect size bias was accompanied by a lower number of SLE risk alleles in the Southern subjects, both patients and controls, the difference being more marked between the controls (P = 1.1 × 10 -8) than between the Southern and Central European patients (P = 0.016). Seven of these SNPs showed significant allele frequency clines.Conclusion: Our findings showed a bias to larger effect sizes of SLE loci in the Southern Europeans relative to the Central Europeans together with clines of SLE risk allele frequencies. These results indicate the need to study risk allele clines and the implications of the polygenic model of inheritance in SLE.
AB - Introduction: We aimed to investigate whether the effect size of the systemic lupus erythematosus (SLE) risk alleles varies across European subpopulations.Methods: European SLE patients (n = 1,742) and ethnically matched healthy controls (n = 2,101) were recruited at 17 centres from 10 different countries. Only individuals with self-reported ancestry from the country of origin were included. In addition, participants were genotyped for top ancestry informative markers and for 25 SLE associated SNPs. The results were used to compare effect sizes between the Central Eureopan and Southern European subgroups.Results: Twenty of the 25 SNPs showed independent association with SLE, These SNPs showed a significant bias to larger effect sizes in the Southern subgroup, with 15/20 showing this trend (P = 0.019) and a larger mean odds ratio of the 20 SNPs (1.46 vs. 1.34, P = 0.02) as well as a larger difference in the number of risk alleles (2.06 vs. 1.63, P = 0.027) between SLE patients and controls than for Central Europeans. This bias was reflected in a very significant difference in the cumulative genetic risk score (4.31 vs. 3.48, P = 1.8 × 10 -32). Effect size bias was accompanied by a lower number of SLE risk alleles in the Southern subjects, both patients and controls, the difference being more marked between the controls (P = 1.1 × 10 -8) than between the Southern and Central European patients (P = 0.016). Seven of these SNPs showed significant allele frequency clines.Conclusion: Our findings showed a bias to larger effect sizes of SLE loci in the Southern Europeans relative to the Central Europeans together with clines of SLE risk allele frequencies. These results indicate the need to study risk allele clines and the implications of the polygenic model of inheritance in SLE.
UR - http://www.scopus.com/inward/record.url?scp=84860224945&partnerID=8YFLogxK
U2 - 10.1186/ar3818
DO - 10.1186/ar3818
M3 - Article
SN - 1478-6354
VL - 14
JO - Arthritis Research and Therapy
JF - Arthritis Research and Therapy
IS - 2
M1 - R94
ER -